This paper examines Philip Morris International (PM) as a publicly traded company listed on the New York Stock Exchange, with a focus on investor relations. It reviews the company's stock performance, noting a one-year holding period return of approximately 63% as of May 2011. The paper profiles PM's executive leadership, including CEO Louis C. Camilleri and CFO Hermann Waldemer, and highlights the company's significant international market presence across roughly 180 countries. It also raises ethical questions about profiting from a product widely recognized as harmful to public health, while acknowledging the role of market forces and individual consumer choice.
This paper examines Philip Morris International, a publicly traded cigarette manufacturer, through the lens of investor relations. This company is particularly interesting due to the nature of its product — cigarettes — and the well-documented dangers they pose to the health of individuals who choose to purchase and use them. The broader question of profiting from a product with such social costs also speaks to what drives decision-making in today's financial markets. Philip Morris International presents a compelling case study precisely because its financial success exists in tension with public health concerns.
Philip Morris International (ticker: PM) is listed on the New York Stock Exchange. As of May 20, 2011, the stock was last traded at $70.19 per share. The company describes itself as "the leading international tobacco company, with some of the world's top 15 brands, including the Marlboro brand, the number one cigarette brand worldwide." One year prior, the stock price was below $43, representing a one-year holding period return of approximately 63%.
This level of growth raises an important question: what responsibility, if any, does Philip Morris International bear toward the public given the known harms of its product? Similarly, what role does the New York Stock Exchange play when it facilitates trading in companies whose core product is widely considered dangerous to public health?
The chairman and chief executive officer of PM is Louis C. Camilleri, who has held this position since March 28, 2008, following the company's separation from its former parent, Altria Group Inc. The chief financial officer is Hermann Waldemer. Together, they lead an organization with an extensive global footprint and significant influence in international tobacco markets.
The company's leadership describes Philip Morris International as a leading international business with products sold in approximately 180 countries. In 2010, the company held an estimated 16.0% share of the total international cigarette market outside the United States, or 27.6% when excluding both the People's Republic of China and the United States. This international reach makes PM a particularly powerful and wide-ranging organization. Smoking regulations and restrictions vary considerably depending on the region of the world, and this variation creates differentiated market conditions that the company navigates across its global operations.
"Global sales footprint and market share data"
"Health concerns, social responsibility, and market future"
You’re 64% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.